Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.925 GBX | -.--% | +10.00% | +10.00% |
02/04 | Sareum ups retail offer; SThree nabs former ITV exec | AN |
02/02 | Advanced Oncotherapy eyes USD15 million tranche in February | AN |
Business Summary
Number of employees: 174
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 27/14/27 | |
Director of Finance/CFO | - | 01/16/01 | |
Michael Sinclair
CHM | Chairman | 82 | 16/06/16 |
Jonathan Farr
CTO | Chief Tech/Sci/R&D Officer | - | 14/17/14 |
Ed Lee
COO | Chief Operating Officer | - | 01/17/01 |
David Navas
IRC | Investor Relations Contact | - | - |
Henry Clarke
SEC | Corporate Secretary | - | 19/19/19 |
Bridget Biggar
HRO | Human Resources Officer | - | 01/16/01 |
Graham Pughe
AUD | Comptroller/Controller/Auditor | - | 01/12/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 29/20/29 |
Michael Sinclair
CHM | Chairman | 82 | 16/06/16 |
Hans von Celsing
BRD | Director/Board Member | 74 | 26/17/26 |
Director/Board Member | 73 | 01/13/01 | |
Ren Hua Zhang
BRD | Director/Board Member | 58 | 28/18/28 |
Director/Board Member | 72 | 26/13/26 | |
Director/Board Member | 74 | 09/17/09 | |
Chief Executive Officer | 49 | 27/14/27 | |
Stephen Myers
BRD | Director/Board Member | 78 | 26/17/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 542,573,869 | 284,689,154 ( 52.47 %) | 0 | 52.47 % |
Company contact information
Advanced Oncotherapy Plc
4 Tenterden Street Third Floor
W1S 1TE, London
+44 20 3617 8728
http://advancedoncotherapy.comSector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.00% | 11.92M | |
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
-0.08% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |
- Stock Market
- Equities
- AVO Stock
- Company Advanced Oncotherapy plc